உணர்ச்சி பல்கலைக்கழகம் ஒன்றுபட்டது மாநிலங்களில் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Hyderabad s Yashoda Hospitals to conduct Phase 3 trial of Molnupiravir ​ By IANS | ​ 0 Views Hetero inks deal with MSD to manufacture Molnupiravir .. Image Source: IANS News Hyderabad, May 21 : Hyderabad s Yashoda Hospitals will start Phase 3 trials of Molnupiravir, in association with NatcoPharma, in their Somajigida unit, the private hospital announced on Friday. NatcoPharma has already received approval from Drug Controller General of India (DCGI) for conducting clinical trials for oral administration of Molnupiravir capsules for patients with mild and moderate Covid-19 symptoms. The clinical trials at Yashoda Hospitals will entail the Covid patient volunteers to take 800 mg twice a day without being admitted in the hospital, since it is a OPD (out-patient department) based clinical trial. The patient volunteers regular interactions with their physicians on day 5, day 10 and day 15 for their follow up cycle at the hospital.

Andhra pradeshUnited kingdomLingaiah amidalyaScientists at emory university united statesYashoda hospitalsDrug controller generalMedical directorEmory university united statesஆந்திரா பிரதேஷ்ஒன்றுபட்டது கிஂக்டம்யஷோட மருத்துவமனைகள்மருந்து கட்டுப்படுத்தி ஜநரல்மருத்துவ இயக்குனர்உணர்ச்சி பல்கலைக்கழகம் ஒன்றுபட்டது மாநிலங்களில்